Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease risk management in Belgium
by Natalia S. Shilnikova, Daniel Krewski, Michael G. Tyshenko
International Journal of Risk Assessment and Management (IJRAM), Vol. 14, No. 3/4, 2010

Abstract: Large imports of cattle and meat and bone meal from countries potentially affected by bovine spongiform encephalopathy (BSE) may have led to the BSE agent entering Belgium, and the occurrence of domestic BSE cases. The first case was confirmed in 1997. The ability to avoid amplification of incoming infectivity, as well as to reduce already circulating infectivity, was greatly improved in Belgium in 1999. The number of BSE cases decreased after peaking in 2001. No BSE cases were identified in 2007, at which time the European Commission recognised Belgium as a country with 'controlled BSE risk'. To date, there have been no reported cases of variant Creutzfeldt-Jakob disease (vCJD) in Belgium. Recent enhancements to food safety and blood safety systems, along with safeguards against transmission of Creutzfeldt-Jakob disease (including vCJD) in hospital environments, will help to prevent the occurrence of vCJD in Belgium.

Online publication date: Sat, 18-Sep-2010

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Risk Assessment and Management (IJRAM):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com